These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37081104)

  • 1. Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study.
    Irún P; Gracia R; Piazuelo E; Pardo J; Morte E; Paño JR; Boza J; Carrera-Lasfuentes P; Higuera GA; Lanas A
    Sci Rep; 2023 Apr; 13(1):6497. PubMed ID: 37081104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
    Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
    Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute severe SARS COVID-19 patients produce pro-resolving lipids mediators and eicosanoids.
    Regidor PA; De La Rosa X; Santos FG; Rizo JM; Gracia Banzo R; Silva RS
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6782-6796. PubMed ID: 34787883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients.
    Archambault AS; Zaid Y; Rakotoarivelo V; Turcotte C; Doré É; Dubuc I; Martin C; Flamand O; Amar Y; Cheikh A; Fares H; El Hassani A; Tijani Y; Côté A; Laviolette M; Boilard É; Flamand L; Flamand N
    FASEB J; 2021 Jun; 35(6):e21666. PubMed ID: 34033145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients.
    Palmas F; Clarke J; Colas RA; Gomez EA; Keogh A; Boylan M; McEvoy N; McElvaney OJ; McElvaney O; Alalqam R; McElvaney NG; Curley GF; Dalli J
    PLoS One; 2021; 16(8):e0256226. PubMed ID: 34437568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS/MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolites.
    Le Faouder P; Baillif V; Spreadbury I; Motta JP; Rousset P; Chêne G; Guigné C; Tercé F; Vanner S; Vergnolle N; Bertrand-Michel J; Dubourdeau M; Cenac N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():123-33. PubMed ID: 23831705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabololipidomic profiling of functional immunoresolvent clusters and eicosanoids in mammalian tissues.
    Norris PC; Serhan CN
    Biochem Biophys Res Commun; 2018 Oct; 504(3):553-561. PubMed ID: 29524409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
    Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
    Front Immunol; 2022; 13():893792. PubMed ID: 35812400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators.
    Hachem M
    Biochimie; 2021 May; 184():95-103. PubMed ID: 33639198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid mediators are detectable in the nasal epithelium and differ by asthma status in female subjects.
    Johnson RK; Manke J; Campbell M; Armstrong M; Boorgula MP; Pinheiro G; Santana CVN; Mathias RA; Barnes KC; Cruz A; Reisdorph N; Figueiredo CA
    J Allergy Clin Immunol; 2022 Oct; 150(4):965-971.e8. PubMed ID: 35304161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.
    Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR
    Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.
    Zaid Y; Doré É; Dubuc I; Archambault AS; Flamand O; Laviolette M; Flamand N; Boilard É; Flamand L
    J Allergy Clin Immunol; 2021 Aug; 148(2):368-380.e3. PubMed ID: 34111453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of arachidonic cascade in COVID-19 infection: A review.
    Ripon MAR; Bhowmik DR; Amin MT; Hossain MS
    Prostaglandins Other Lipid Mediat; 2021 Jun; 154():106539. PubMed ID: 33592322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in Pulmonary Eicosanoids and Specialized Pro-Resolving Mediators in Response to Ozone Exposure.
    Yaeger MJ; Reece SW; Kilburg-Basnyat B; Hodge MX; Pal A; Dunigan-Russell K; Luo B; You DJ; Bonner JC; Spangenburg EE; Tokarz D; Hannan J; Armstrong M; Manke J; Reisdorph N; Tighe RM; Shaikh SR; Gowdy KM
    Toxicol Sci; 2021 Aug; 183(1):170-183. PubMed ID: 34175951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased oxidative stress and altered urinary oxylipidome by intravenous omega-3 fatty acid emulsion in a randomized controlled trial of older subjects hospitalized for COVID-19.
    Pawelzik SC; Arnardottir H; Sarajlic P; Mahdi A; Vigor C; Zurita J; Zhou B; Kolmert J; Galano JM; Religa D; Durand T; Wheelock CE; Bäck M
    Free Radic Biol Med; 2023 Jan; 194():308-315. PubMed ID: 36509313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local shifts in inflammatory and resolving lipid mediators in response to tendon overuse.
    Markworth JF; Sugg KB; Sarver DC; Maddipati KR; Brooks SV
    FASEB J; 2021 Jun; 35(6):e21655. PubMed ID: 34042218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum midkine levels in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients.
    Ketenci S; Uygar Kalaycı M; Dündar B; Duranay R; Şükrü Aynacıoğlu A
    Int Immunopharmacol; 2022 Sep; 110():108939. PubMed ID: 35717836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Mediator Metabolomics Via LC-MS/MS Profiling and Analysis.
    Dalli J; Colas RA; Walker ME; Serhan CN
    Methods Mol Biol; 2018; 1730():59-72. PubMed ID: 29363065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.